Sofie (United States) has no DMF, CEP or site registration linked in our records. 42 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Sofie: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sofie
Overview
Sofie is a pharmaceutical company headquartered in Dulles, United States.
FDA compliance signals
42 FDA enforcement records linked to this company.
- 4832026-01-15
Determination need for investigation
- 4832026-01-15
Record quality
- 4832025-10-28
Adequate controls (general)
- 4832025-10-28
Determination need for investigation
- 4832025-10-28
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832025-10-28
Personnel not qualified
- 4832025-09-03
Adequate controls (general)
- 4832025-08-28
Equipment procedures
- 4832025-08-07
Equipment procedures
- 4832025-08-07
Personnel not qualified
- 4832025-08-07
Data and documentation review
- 4832025-07-25
Conform to specs prior to release
- 4832025-07-25
Written QA procedures established, followed
- 4832024-01-22
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832024-01-22
Personnel not qualified
- 4832024-01-22
Adequate controls (general)
- 4832023-08-11
Documentation of Non-Conforming Product Investigation
- 4832023-08-11
Complaint review
- 4832023-08-11
Labeling and product mix-ups
- 4832023-08-11
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832023-01-20
Written QA procedures established, followed
- 4832023-01-20
Equipment
- 4832023-01-20
Before implementing new procedure establish and document accuracy etc.
- 4832023-01-20
Written complaint procedures
- 4832023-01-20
Correction of problems
- 4832023-01-20
Adequate controls (general)
- 4832023-01-20
Equipment procedures
- 4832023-01-20
Determination need for investigation
- warning_letter2019-10-10
FDA Warning Letter (drug product)
- 4832019-04-12
Analytical methods
- 4832019-04-12
Written complaint procedures
- 4832019-04-12
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832019-02-05
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832019-02-05
Initials, signature, date
- 4832019-02-05
Personnel not qualified
- 4832019-02-05
Final dated signature
- 4832018-12-03
Orderly handling, prevention of mix-ups, prevention of contamination
- 4832018-12-03
Written QA procedures established, followed
- 4832018-12-03
Contamination, chemical or physical change, deterioration
- 4832016-08-04
Investigation of nonconforming product
- 4832016-01-15
Written QA procedures established, followed
- warning_letter2008-10-24
FDA Warning Letter (drug product)
Is this Sofie?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.